Felix Chien
Family Medicine · New York, NYNPI 1255368163
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Gilead at 32.0% of the total.
Across 91 payments — averaging $59.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$2K
- AstraZeneca$1K
- Travere Therapeutics, Inc.$390
- Bayer$279
- Viiv Healthcare Company$278
- Boehringer Ingelheim$275
- plus $1K from 13 others
What the payments were for
- Food & beverage$5,406100%
- Education$210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 34 | $1,735 |
| AstraZeneca | 12 | $1,185 |
| Travere Therapeutics, Inc. | 3 | $390 |
| Bayer | 3 | $279 |
| Viiv Healthcare Company | 7 | $278 |
| Boehringer Ingelheim | 3 | $275 |
| Amgen | 4 | $181 |
| Johnson & Johnson | 2 | $170 |
| Stryker | 1 | $167 |
| Esperion Therapeutics, Inc. | 1 | $150 |
| Exact Sciences | 6 | $145 |
| Novo Nordisk | 2 | $125 |
| Intuitive Surgical | 1 | $123 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $109 |
| Bausch Health US, LLC | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| OPKO Pharmaceuticals, LLC | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,427 in reported general payments places this provider in the 85th percentile of 4,321 family medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amlodipine Besylate-BenazeprilAmlodipine Besylate/Benazepril | 12 | $106 |
| Finasteride | 13 | $54 |
| Atenolol | 13 | $31 |
| Atorvastatin Calcium | 11 | $30 |
| Metformin Hcl | 12 | $29 |
| Hydrochlorothiazide | 12 | $10 |
Paid to pharmacies, not to this prescriber.
Other family medicine in New York
- Matthew PabisNew York$222K
- Eric BatesNew York$171K
- Alexander BlinskiNew York$159K
- Jason KindtNew York$122K
- Mahyar EidgahNew York$76K
- Anthony LyonNew York$65K
- Daniel BowersNew York$44K
- Angelina LauchangcoNew York$26K
- Orin DouglasNew York$25K
- Punyadech PhotangthamNew York$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.